Clinical Implications of Exenatide as a Twice-Daily or Once-Weekly Therapy for Type 2 Diabetes
Year: 2011
Type: review
Source: Postgraduate Medicine
Authors: Vanita R. Aroda, Mary Beth DeYoung
Institution: MedStar Health Research Institute
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: exenatide, exendin-4, type 2 diabetes, GLP-1 receptor agonists, twice-daily dosing, weekly dosing, glycemic control, HbA1c, fasting blood glucose, postprandial blood glucose, weight loss, blood pressure, lipid profile, gastrointestinal adverse effects, pancreatitis, renal dysfunction, treatment satisfaction, real-world data, drug safety
Open Access status: closed
Funders: Amylin Pharmaceuticals, Merck, Novo Nordisk
OpenAlex ID: W2152141170
